Pfizer finds COVID-19 drug candidate, plots summer testing

Pfizer has found a leading experimental drug candidate against SARS-CoV-2 and is planning to test the drug in the coming months.

This is according to The Wall Street Journal, which was told the facts by Pfizer’s R&D chief Mikael Dolsten in an interview with the financial paper.

He told the WSJ that early R&D has shown its candidate blocks the new virus, which causes COVID-19, from replicating, with hopes it could slow or stop the spread of the virus in patients with mild to moderate symptoms.